LHCG LHC Group Inc.

LHC Group’s CMS Star Ratings Continue to Lead Home Healthcare Industry

LHC Group, Inc. (NASDAQ: LHCG) has again emerged as the top performer among national publicly traded home healthcare providers in the latest Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Rating System results – released in July 2017.

The CMS star ratings results are released quarterly and rank providers in two categories: “Quality of Patient Care” and “Patient Satisfaction.” The ratings system was instituted by CMS as part of its Home Health Compare website to provide a “tool for consumers to use when choosing a home health care provider.”

In the July 2017 results, LHC Group saw 35 of its home health locations achieve a five-star rating in both categories. In addition, 209 of the company’s locations achieved a four-star rating or better in each category, while another 63 locations earned four stars in at least one category.

Jefferies Group LLC – a New York-based global investment bank and institutional securities firm that provides financial advisory services – said in a report also released in July (https://goo.gl/mUrBRR) that “LHCG significantly outperformed the industry in the percentage of its facilities rating four stars and above.”

The firm’s analysis shows LHC Group maintaining its position as the industry leader in both quality and patient satisfaction, with ratings “well above” the industry average. The July report further states that “…LHCG continues to deliver improved Stars performance on both quality and patient satisfaction categories nationally.”

LHC Group is a national provider of post-acute care services with over 13,000 employees operating more than 400 locations in 28 states.

The Jefferies’ July report also affirms their analysts’ view that “…publicly-traded providers deliver superior care quality vs. smaller peers and that they remain on track for upside-driving bonus payments as CMS rolls out value-based payments…”

The report further states: “Hospitals are increasingly focused on discharging patients to optimal cost and quality settings/providers, due to factors such as readmission penalties and outcomes-based payment programs (ACOs, bundled payments). We believe SS (same-store) admission trends for the public home health providers will continue to be strong in Q2 (2017), providing validation that as care quality becomes a more important factor for referrals (as well as bonus payments from hospital and/or payor partners), Stars ratings should drive volumes toward high-quality providers…”

CMS star ratings are highly respected performance indicators for home health providers and are viewed as a key differentiator in the post-acute care industry. As healthcare providers seek ways to better support the health and well-being of their patients both within and outside hospital settings, effective post-acute care solutions are growing in importance.

“LHC Group’s ability to both maintain and improve our performance in leading the CMS star ratings for our industry is no accident,” said Keith Myers, LHC Group chairman and CEO. “We operate under the firm belief that there is no aspect of our business – no matter how seemingly insignificant – that does not ultimately impact quality. The consistently high performances achieved by our local teams around the nation are the result of a company-wide commitment to quality at every level of our organization.

“We agree with respected analysts – like Jefferies – in their view that quality metrics will remain the preferred standard for evaluating healthcare providers, and that the ratings provide ‘…a quantifiable measure and differentiation point for provider quality that could encourage MA plans to utilize more home nursing services while also offering adequate and rational reimbursement for high-quality service,’” said Myers.

LHC Group’s dedication to producing quality patient outcomes is facilitated in part through proactive and consistent internal monitoring and review that helps quickly identify and address opportunities for improvement at the agency level. The ability to design and implement improvements in real time at a local level has helped the company achieve and maintain its position as the post-acute care industry’s recognized leader in quality.

About LHC Group, Inc.

LHC Group, Inc. is a national provider of post-acute healthcare services, providing quality, cost-effective healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice, community-based services, and facility-based services.

EN
08/08/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LHC Group Inc.

LHC GROUP reduces its risk exposure and slightly improves to Neutral

The independent financial analyst theScreener just allocated a lower risk rating to LHC GROUP (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly improved and can be qualified as moderately risky. theScreener considers that these elements merit an overall rating upgrade to Neutral. As of the analysis date April 1, 2022, the closing price was USD 168.13 and its expect...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - D2021 10 12

LPL Financial (LPLA) has created a powerful platform to empower independent and smaller scale wealth advisors to compete with the big players like Merrill Lynch and Morgan Stanley. Uniform Accounting highlights the company's operational improvements that the market is missing, indicating equity upside. AMD Q2 2021 Embedded Expectations Analysis – Market expectations are for Uniform ROA to expand, but management may have concerns about data center revenue growth, EPYC processors, and operating c...

Valens Research
  • Valens Research

LHCG - Embedded Expectations Analysis - 2021 10 11

LHC Group, Inc. (LHCG:USA) currently trades around corporate averages relative to UAFRS-based (Uniform) earnings, with a 24.4x Uniform P/E, implying bullish expectations for the firm. However, management may have concerns about staffing challenges, cost management, and admissions growth. Specifically, management may lack confidence in their ability to gain stronger physician support for taking higher acuity patients into the home, forecast patient volumes and characteristics, and sustain organi...

LHC Group Inc: 1 director

A director at LHC Group Inc sold 5,000 shares at 201.620USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

LHC Group to present at the Baird 2020 Global Healthcare Conference

LHC Group to present at the Baird 2020 Global Healthcare Conference LAFAYETTE, La., Sept. 08, 2020 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020. The presentation will begin at 8:30 a.m. Eastern time, and a live will be available. To access the live webcast, listeners should go to the section of the Company’s website, , approximately 15 minutes prior to the event to register and download any necessary software. About LHC Group, Inc.LHC Group, Inc. is a nat...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch